GFRP confined concrete specimens. by Qingwen Li (1510687)

Subjects:

13 Compressive strength of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

The comparison of the Spectral Exponent in hemispherotomy with a reference pediatric sample across wakefulness and NREM Sleep reveal values compatible with deep sleep in the isolat... by Michele Angelo Colombo (22446342)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Results of the mediation model test for the elevated inhibition function in the relationship between elevated mindfulness level and decreased mobile phone addiction index. by Jizhao Li (5856650)

DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic inde... by Juanjuan Li (399633)

Subjects:

Socio-demographic characteristics of the population. by Sara Saleh (6733619)

Subjects:

Knowledge, attitude and practice scores in the general population and according to regions. by Sara Saleh (6733619)

Subjects:

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the knowledge scores. by Sara Saleh (6733619)

Subjects: